– USA, TX – Michal Morrison Inc., the science-first, biotech skincare company with the exclusive, patented breakthrough molecule – βSTEM6, today announced the appointment of Dr. Gail Naughton (Ph.D.) to its Board of Directors and the Science Advisory Team.
AboutDr. Gail K. Naughton
Dr. Naughton, a global leader in regenerative medicine for the past 35 years, has successfully developed significant cell-based therapeutics and bioengineered tissue technologies throughout her career. Her pioneering work in the field of tissue engineering and regenerative medicine combined with her business acumen has seen her take four products from concept, through FDA approval, to market launch as well as taking two companies to publicly traded NASDAQ listings.
“I am honored to join the scientists and the board at Michal Morrison Inc. The company’s patented βSTEM6 technology represents an unprecedented achievement in biotech skincare. βSTEM6 is the only molecule of its kind validated by studies to support the skin’s own regenerative process. I am thrilled to be working with Dr. Michael Kahn Ph.D., and Dr. Fuqiang Ruan, the visionary scientists who developed βSTEM6 technology,” said Dr. Naughton.
Dr. Gail Naughton spent over 35 years researching the tissue engineering process, holds over 140 U.S. and foreign patents, and founded two regenerative medicine companies. She founded Histogen in 2007 to focus on the development of novel solutions based on the products of cells grown under simulated embryonic conditions. She invented this technology at Histogen and through May of 2021 served in a variety of executive capacities including Chairman, CEO, and CSO.
About MICHAL MORRISON Inc.
MICHAL MORRISON Inc. is a science-first, biotech skincare company established in stem cell science, supported by its patented βSTEM6 molecule. Founded in 2020 by Michal Ann Morrison an entrepreneur and former archeologist, whose scientific studies informed her ‘science-first’ approach to developing her eponymous brand. βSTEM6, a novel composition of matter that supports stem cells in awakening the millions of cells responsible for healthy-looking skin, is a new supermolecule at the forefront of biomimetic skincare. Genesis βSTEM6 Molecular Serum debuted in spring 2023. Michal Morrison Inc. has been honored by the beauty industry for its innovative technology and exquisite brand design. The company was a finalist for Best Innovation Breakthrough Technology and Best Product Packaging Design by Beauty Matter NEXT Award Summit 2023 and received the Silver Award for Package of the Year (2023) from the New Jersey Packaging Executives Club.
For more information: https://www.michalmorrison.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
